A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

Today, antibiotics are the third largest-selling ... manufactured by Micrologix Biotech (Vancouver, BC). The two-part phase II trials are intended to assess the safety, pharmacokinetics, and ...

You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics. But the FDA ...

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

tuberculosis.” UC San Diego biotech spinoff tackles global health issue Linnaeus Bioscience was launched in 2012 with a UC ...

Antibiotics are indispensable for treating bacterial infections. But why are they sometimes ineffective, even when the bacteria are not resistant? In their latest study, researchers challenge the ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

The data suggests that the body's use of nutrient scarcity as a defense mechanism may actually enable bacteria's survival in the long run.